2025
27 November, 2025
FluoGuide A/S publishes Interim Report Q3 2025
Copenhagen, Denmark, 27 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its...
25 November, 2025
FluoGuide signs collaboration agreement with ZEISS
Copenhagen, Denmark, 25 November 2025 – FluoGuide A/S, a biotech company specializing in precision cancer surgery, announces...
24 November, 2025
Minutes from Extraordinary General Meeting in FluoGuide A/S
Copenhagen, Denmark, 24 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company” held an extraordinary...
24 November, 2025
Invitation to FluoGuide A/S (Nasdaq: FLUO) webcast on 27 November 2025
FluoGuide A/S will publish its Interim Report Q3 2025 on Thursday 27 November 2025. The following event will take place later that...
5 November, 2025
FluoGuide strengthens leadership to advance clinical program and regulatory approval strategy
Copenhagen, Denmark 4 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company...
5 November, 2025
FluoGuide convenes an extraordinary general meeting
Copenhagen, Denmark 4 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby invites shareholders...
Copenhagen, Denmark, 3 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) announces that it...
FluoGuide A/S announces that two of its shareholders, both of whom hold management and/or board positions in the Company, have entered...
3 November, 2025
FluoGuide A/S completes directed share issue of SEK 104 million
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA...
